JPS58222019A - 肝疾患治療剤 - Google Patents

肝疾患治療剤

Info

Publication number
JPS58222019A
JPS58222019A JP10317382A JP10317382A JPS58222019A JP S58222019 A JPS58222019 A JP S58222019A JP 10317382 A JP10317382 A JP 10317382A JP 10317382 A JP10317382 A JP 10317382A JP S58222019 A JPS58222019 A JP S58222019A
Authority
JP
Japan
Prior art keywords
hepatocytes
liver
compound
treatment agent
liver disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10317382A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0158163B2 (enExample
Inventor
Munehiro Tomikawa
宗博 富川
Minoru Nakaoka
中岡　稔
Junichiro Wakasugi
若杉　潤一郎
Hideo Hakusui
伯水　英夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Nippon Kayaku Co Ltd
Nihon Nohyaku Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Nippon Kayaku Co Ltd
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd, Nippon Kayaku Co Ltd, Nihon Nohyaku Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP10317382A priority Critical patent/JPS58222019A/ja
Publication of JPS58222019A publication Critical patent/JPS58222019A/ja
Publication of JPH0158163B2 publication Critical patent/JPH0158163B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP10317382A 1982-06-16 1982-06-16 肝疾患治療剤 Granted JPS58222019A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10317382A JPS58222019A (ja) 1982-06-16 1982-06-16 肝疾患治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10317382A JPS58222019A (ja) 1982-06-16 1982-06-16 肝疾患治療剤

Publications (2)

Publication Number Publication Date
JPS58222019A true JPS58222019A (ja) 1983-12-23
JPH0158163B2 JPH0158163B2 (enExample) 1989-12-11

Family

ID=14347110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10317382A Granted JPS58222019A (ja) 1982-06-16 1982-06-16 肝疾患治療剤

Country Status (1)

Country Link
JP (1) JPS58222019A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010176A1 (fr) * 1990-12-07 1992-06-25 Taisho Pharmaceutical Co., Ltd. Agent therapeutique contre les maladies du foie

Also Published As

Publication number Publication date
JPH0158163B2 (enExample) 1989-12-11

Similar Documents

Publication Publication Date Title
EP0276317B1 (en) Gamma-l-glutamyl-l-cysteine ethyl ester and drug containing it as effective ingredient
Muller et al. Cirrhosis caused by methotrexate in the treatment of psoriasis
EP1098651B1 (de) Neue urokinase-inhibitoren
Freeman et al. Inhibition of system A amino acid transport and hepatocyte proliferation following partial hepatectomy in the rat
CN1978445A (zh) 一种化合物及其制备方法和应用
Wang et al. Puerarin Ameliorates 5-Fluorouracil–Induced Intestinal Mucositis in Mice by Inhibiting JAKs
Xu et al. Silibinin Schiff base derivatives counteract CCl4-induced acute liver injury by enhancing anti-inflammatory and antiapoptotic bioactivities
Zhu et al. Dynamically deformable protein delivery strategy disassembles neutrophil extracellular traps to prevent liver metastasis
JP3168669B2 (ja) 肝再生促進剤
JPS58222019A (ja) 肝疾患治療剤
Fernández‐Martínez et al. Effects of thalidomide and 3‐phthalimido‐3‐(3, 4‐dimethoxyphenyl)‐propanamide on bile duct obstruction‐induced cirrhosis in the rat
CA2226340A1 (en) Drug for ameliorating brain diseases
CN103110613B (zh) 饱和胺类化合物在制备抗辐射损伤药物中的应用
CN119424436A (zh) 化合物rociletinib通过抑制铁死亡在制备急性肝损伤的药物中的应用
US20230090982A1 (en) Drug for treating coronaviral and retroviral infections and hepatitis c
EP1067138B1 (en) Hydroxyproline derivatives
JP4255138B2 (ja) 脳疾患治療剤
JPS62423A (ja) 肝疾患治療剤
JPH05238939A (ja) 肝炎治療剤
CN101342160B (zh) 海洋溴酚在制备治疗抗血栓形成作用药物中的应用
Marshak et al. Mitosis in regenerating liver
EP1549742B1 (en) Method for selection of compounds which inhibit clonal cell growth and use thereof
RU2790828C1 (ru) Гепатопротекторное действие низкомолекулярного миметика NGF
CN112843052B (zh) 表观遗传因子抑制剂2800z在制备抗肝癌药物增敏剂中的应用
JPH1179992A (ja) アポトーシス抑制剤